130.
Altman R. Risk factors in coronary atherosclerosis athero-inflammation: the
meeting point / R. Altman // Thromb. J. – 2003. – Vol. 1, № 1. – P. 4.
131.
Angiotensin II-mediated endothelial dysfunction: role of poly(ADP-ribose)
polymerase activation / C. Szabo [et al.] // Mol. Med. – 2004. – Vol. 10, № 1-6. –
P. 28-35.
132.
Angiotensin-converting enzyme inhibition with quinapril improves endothelial
vasomotor dysfunction in patients with coronary artery disease. The TREND
(Trial on Reversing Endothelial Dysfunction) Study / G. B. J. Mancini [et al.] //
Circulation. – 1996. – Vol. 94, № 3. – P. 258-265.
133.
Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed
rabbits / A. L. Willix [et al.] // Arteriosclerosis. – 1985. – Vol. 5. – P. 250-255.
134.
Apoptosis in vascular endothelial cells caused by serum deprivation, oxidative
stress and transforming growth factor-beta / N. Hogg [et al.] // Endothelium. –
1999. – Vol. 7, № 1. – P. 35-49.
135.
Association of sICAM-1 and MCP-1 with coronary artery calcification in
families enriched for coronary heart disease or hypertension: the NHLBI Family
Heart Study / W. Tang [et al.] // BMC. Cardiovasc. Disord. – 2007. – Vol. 7. – P.
30.
136.
Associations of C-reactive protein with measure of obesity, insulin resistance,
and subclinical atherosclerosis in healthy, middle-age women / A. E. Hak [et al.] //
Arterioscler. Thromb. Vasc. Biol. – 1999. – Vol. 19, № 8. – P. 1986-1991.
137.
Atheroprotective mechanisms activated by fluid shear stress in endothelial
cells / B. C. Berk [et al.] // Drug News Perspect. – 2002. – Vol.15, № 3. – P. 133-
139.
138.
Behavioral strategies of individuals who have maintained long-term weight
losses / M. T. McGuire [et al.] // Obes. Res. – 1999. – Vol. 7. – P. 334-341.
139.
Biegelsen E. S. Endotelial function and atherosclerosis / E. S. Biegelsen, J.
Loscalso // Coron. Artery Dis. – 1999. – Vol. 10, № 4. – P. 241-256.
